Minimal GVHD following in-vitro Tcell–depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors-Reference-Cited by-同舟云学术

Minimal GVHD following in-vitro Tcell–depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors

Published:2003-10 Issue:10 Volume:31 Page:865-872
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Barge Renée M.Y,Osanto Susanne,Marijt W.A.F.Erik,Starrenburg C.W.J.Ingrid,Fibbe Willem E,Nortier J.W.R.Hans,Falkenburg J.H.Frederik,Willemze Roel

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference32 articles.

1. Antileukemic effect of chronic graft-vs-host disease: contribution to improved survival after allogeneic marrow transplantation;Weiden;N Engl J Med,1981

2. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion;Goldman;Ann Intern Med,1988

3. T cells recognizing leukemic CD34+ progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation;Smit;Proc Natl Acad Sci U S A,1998

4. Transplant-lite: Induction of graft-vs-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor–cell transplantation as treatment for lymphoid malignancies;Khouri;J Clin Oncol,1998

5. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematological diseases;Slavin;Blood,1998

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Promiscuity of Peptides Presented in HLA-DP Molecules from Different Immunogenicity Groups Is Associated With T-Cell Cross-Reactivity;Frontiers in Immunology;2022-02-16

2. Minor histocompatibility antigens as targets for T-cell immunotherapy;Russian journal of hematology and transfusiology;2021-10-25

3. Effect of alemtuzumab-based T-cell depletion on graft compositional change in vitro and immune reconstitution early after allogeneic stem cell transplantation;Cytotherapy;2021-01

4. Priming of Allo-HLA-DP-Specific Reactivity from the Naïve T Cell Compartment Is Not Exclusively Mediated by Professional Antigen-Presenting Cells;Biology of Blood and Marrow Transplantation;2020-07

5. The allogeneic HLA-DP-restricted T-cell repertoire provoked by allogeneic dendritic cells contains T cells that show restricted recognition of hematopoietic cells including primary malignant cells;Haematologica;2018-09-20